Effects of surgery on ischaemic mitral regurgitation: a prospective multicentre registry (SIMRAM registry)
1 Department of Cardiology, University Hospital, CHU Sart Tilman, B-4000 Liège, Belgium
2 CHU de Ponchaillou, Rennes, France
3 CHIREC, Site Braine l'Alleud, Belgium
4 AZ-VUB, Brussels, Belgium
5 Hôpital Henri Mondor, Créteil, France
6 Hôpital Bichat, Claude-Bernard, Paris, France
7 Hôpital Georges Pompidou, Paris, France
8 Hôpital Laval, Québec; Canada
9 Saint Augustin, Bordeaux, France
10 Hjertemedicinsk Klinik, Rigshospitalet, Denmark
11 University of Milan, Milan, Italy
12 CHUR, Amiens, France
13 Haut-Lévêque, Pessac, France
14 Wales College of Medicine, Cardiff, UK
15 Lyon, France
16 Onassis Cardiac, Surgery Center, Athens, Greece
17 Leiden University Medical Center, Leiden, The Netherlands
Received 15 October 2006; accepted after revision 23 December 2006; online publish-ahead-of-print 9 March 2007.
* Corresponding author. Tel: +32 4 366 71 94; fax: +32 4 366 71 95 (P. Lancellotti). E-mail addresses: plancellotti{at}chu.ulg.ac.be, lpierard{at}chu.ulg.ac.be
| Abstract |
|---|
|
|
|---|
Aims: Functional ischaemic mitral regurgitation (IMR) is common in patients with ischaemic left ventricular dysfunction undergoing coronary artery bypass surgery. Although the presence of IMR negatively affects prognosis, the additional benefit of valve repair is debated, particularly with mild IMR at rest. Exercise echocardiography may help identify a subset of patients at higher risk of cardiovascular events by revealing the dynamic component of IMR.
Methods: A large prospective, multicentre, non-randomized registry is designed to evaluate the effects of surgery on IMR at rest and on its dynamic component at exercise (z). SIMRAM will enrol approximately 550 patients with IMR in up to 17 centres with clinical and exercise follow-up for 1 year. Three sets of outcomes will be prospectively assessed and several hypotheses will be tested including determinants of adverse outcome and progressive left ventricular remodeling, efficacy of treatment and role of ischaemia on the dynamic consequences of IMR. Enrolment began in November 2006 and is expected to end by early 2008.
Keywords: Mitral regurgitation; Surgery; Exercise; Echocardiography
| Resting ischaemic mitral regurgitation, prognosis and treatment |
|---|
|
|
|---|
Functional ischaemic mitral regurgitation (IMR) is frequently observed in heart failure patients with chronic ischaemic systolic left ventricular (LV) dysfunction.1,2 IMR develops because of unfavourable alterations in LV geometry with systolic restriction of the mitral leaflets and decreased closing forces.3–10 When present, IMR may exhibit a broad range of severity and when severe, conveys a poor outcome. The more severe the IMR, the worse the prognosis.11–13 This has led to attention focusing towards the amelioration of MR as a therapeutic target that could favourably affect outcome. However, no prospective studies have addressed this issue specifically.14 Moreover, reported results are contradictory and were derived from retrospective observational cohorts of patients with different clinical profiles with potential selection bias.15–17 Nevertheless, although undersized mitral valve annuloplasty has no clear demonstrable survival benefit, it has become the most popular surgical option, usually combined with coronary artery bypass surgery.18–21 Moreover, due to the high complexity of the mechanisms associated with IMR and according to the recurrence rate of IMR after isolated mitral ring annuloplasty, several groups have proposed complementary surgical approaches (subvalvular or ventricular).22–28 However, the effects of these new techniques also remain to be determined. In other words, a lot of questions remain unanswered and prospective large scale registries are required.
| Role of quantitative exercise echocardiography in the assessment of IMR |
|---|
|
|
|---|
Stress testing has been largely validated in the setting of coronary artery disease.29 Conversely, valvular heart disease has been viewed as fairly static and management decisions have been based on resting evaluation alone.30,31 However, the evaluation of IMR only at rest underestimates the full severity of the lesion and its clinical impact.32,33 Indeed, IMR is dynamic with intermittent changes in the degree of regurgitation.34 This dynamic behaviour can be reliably quantified during exercise echocardiography using continuous imaging throughout exercise.35 Both the proximal isovelocity surface area and the Doppler methods emerged as the most accurate. During test, the magnitude of changes in IMR varies from patient to patient and does not correlate with the degree of IMR at rest.36,37 Most patients exhibit a small increase in IMR, whereas others have a large rise or a significant decrease in effective regurgitant orifice. This dynamic nature of IMR relates to changes in LV synchronicity,38–40 in mitral valve configuration (systolic tenting area, systolic expansion of the mitral annulus) and in mitral valve apparatus (papillary muscle displacement) at both ends of tethered leaflets.36,41,42 The decrease in IMR severity during exercise is observed mainly in patients with inferior infarction who have recruitable contractile reserve in the basal segments.36 Dynamic changes in IMR provide additional prognostic information over resting evaluation and unmask a subset of patients at high risk of morbidity and mortality independent from the degree of IMR at rest.43–46 The clinical management of patients with exercise-induced significant increases in IMR as well as the impact of surgery on dynamic IMR have never been examined.
| The SIMRAM registry |
|---|
|
|
|---|
The SIMRAM registry is a large prospective, multicentre, non-randomized study designed to evaluate the effects of surgery on IMR at rest and on its dynamic component at exercise. All participating centres will perform complete echocardiographic examinations including conventional and tissue Doppler imaging; according to the availability, select centres will also perform 3D echocardiographic studies and cardiovascular magnetic resonance imaging. Patients who satisfy all inclusion/exclusion criteria undergo exercise testing before coronary revascularization. The research protocol is approved by the locally appointed ethics committee.
| Patients |
|---|
|
|
|---|
Investigators at up to 17 centers in Europe and in Canada, plan to enroll approximately 550 patients with IMR in the SIMRAM registry. Enrolment started in November 2006 and will be concluded by early 2008.
| Eligibility |
|---|
|
|
|---|
Consecutive patients who present for elective surgical coronary revascularization with significant LV dysfunction (LV ejection fraction < 45%) and at least mild IMR (effective regurgitant orifice
10 mm2) will be prospectively enrolled in the study protocol. All patients must provide informed consent, agree to comply with the study design, and maintain scheduled follow-up visits. | Exclusion criteria |
|---|
|
|
|---|
Exclusions to enrolment include the presence of unstable angina, recent myocardial infarction (<3 months), organic mitral valve disease, atrial fibrillation or flutter before surgery, aortic regurgitation
grade 2, contra-indications to exercise test (refractory angina, ischaemia at low level on a previous stress test), New York Heart Association class IV, and echocardiographic images unsuitable for quantification. Data of patients screened but not included in the final study protocol will be also kept. | Exercise test |
|---|
|
|
|---|
Beta-blockers should be withdrawn the day of the test whenever possible. A symptom-limited graded bicycle exercise test will be performed in a dedicated table. After an initial workload of 25 W maintained for 2 min, the workload will be increased every minute by 10 W. Blood pressure and a 12-lead electrocardiogram will be recorded every 2 min. Two-dimensional and Doppler echocardiographic recordings will be available throughout the test.
| Echocardiographic measurements |
|---|
|
|
|---|
Doppler echocardiography will be standardized to allow central reading at the core laboratory in Liège, Belgium. All 2D echocardiographic and Doppler data will be obtained in digital format and stored on optical disks for off-line analysis at rest and during exercise (Table 1). For each measurement, a minimum of three cardiac cycles will be averaged. Quantification of IMR will be performed by both the quantitative Doppler method using mitral and aortic stroke volumes and the proximal isovelocity surface area method.35,47 The results of these two methods will be averaged allowing calculation of regurgitant volume and effective regurgitant orifice. For the quantitative Doppler method, mitral and aortic stroke volumes will be calculated, and regurgitant volume refers to the difference between these two stroke volumes. Effective regurgitant orifice is the ratio of regurgitant volume to regurgitant time-velocity integral. For the proximal isovelocity surface area method, the radius of the convergence zone will be measured from at least three frames with optimal flow convergence. The largest radius, usually in mid systole, will be selected for analysis. The effective regurgitant orifice is the ratio of regurgitant flow to peak regurgitant velocity. LV end-diastolic and end-systolic volumes and ejection fraction will be measured by the biplane Simpson's rule. Global and regional LV remodelling and mitral valvular deformation will be assessed as described previously. The LV dP/dt – mitral valve closing force – will be estimated from the steepest rising segment of the mitral continuous-wave Doppler regurgitant jet. Colour-tissue Doppler will be performed in the apical views (2-, 3- and 4-chamber) to assess longitudinal myocardial regional function and cardiac synchronicity. Diastolic function and LV filling pressure will be assessed using the mitral inflow and peak velocities during early diastole obtained at the level of mitral annulus.
|
| Data collection |
|---|
|
|
|---|
Clinical information regarding age, gender, New York Heart Association class, coronary risk factors (diabetes mellitus, hypertension, cholesterol level, smoking), and medications use (beta-blockers, ACE inhibitors, angiotensin receptor blockers, nitrates, diuretics, spironolactone, anti-arrhythmic agents) will be recorded. The EuroSCORE will be automatically calculated for each patient. Plasma B-type natriuretic peptide will be measured. Laboratory findings will also include haemoglobin level, renal function and hs C-reactive protein. All echocardiographic recordings will be recorded preoperatively (<1 month before surgery) at rest and during exercise. A routine pre-discharge echocardiographic resting study will be obtained within 1 week of intervention. Follow-up visits will be obtained at rest and at exercise 3 and 12 months after surgery.
| Surgical procedure |
|---|
|
|
|---|
Coronary artery bypass surgery will be performed by an experienced surgical team. The cross clamp and bypass time will be notified as well as the number of vessels treated and the necessity of intra-aortic balloon pumping. The decision to perform mitral valve surgery as well as the technique used for repair will be made by the individual surgeon. Associated subvalvular approach and ventricular reconstruction will be also clearly identified.
| Outcome features |
|---|
|
|
|---|
The study design identifies three sets of outcome measures (Table 2). Clinical end points include all causes of death, cardiovascular death, myocardial infarction, worsening heart failure requiring hospital admission or heart transplantation and changes in New York Heart Association class. Major events will encompass cardiovascular death, myocardial infarction and worsening heart failure. Echocardiographic end points refer to recurrent IMR or persistent IMR at rest or during exercise and its mechanisms, changes in global and regional LV remodelling, changes in LV ejection fraction, and evolution of LV diastolic function. Reverse LV remodelling is defined as a reduction in LV end-systolic volume
15%. Improvement in LV ejection fraction is characterized by an increase
5%. Complex echocardiographic end points examine the effects of surgery in systolic and diastolic synchronicity and on longitudinal function. All end points will be analysed separately or combined as a composite outcome at hospital discharge, and at 3 and 12 months of follow-up.
|
| Discussion |
|---|
|
|
|---|
IMR is common in patients with ischaemic LV dysfunction undergoing coronary artery bypass surgery. Although the presence of IMR negatively affects the prognosis, the benefit of treating it is debated. When IMR is severe, patients are often referred for simultaneous mitral valve surgery. The type of mitral valve intervention remains controversial and pre-operative predictors of repair failure are unknown. In moderate IMR, the clinical utility of mitral valve repair still remains unproven.48,49
Until recently, IMR has been evaluated nearly exclusively at rest. Exercise can however reveal the full severity of the lesion more accurately. Regardless of IMR degree at rest, patients with a dynamic increase in MR during exercise display a worse prognosis. This dynamic behaviour of IMR may accentuate the negative impact of pre-operative mild IMR. The management strategy of such patients has never been investigated.
The SIMRAM project will provide the largest database evaluating the effects of surgery on IMR at rest and on its dynamic component at exercise. Several hypotheses will be covered by this study protocol: the determinants of adverse outcome and progressive LV remodelling, efficacy of treatment, role of ischaemia on the dynamic behaviour of IMR.
We may postulate that pre-operative IMR, both at rest and at exercise, represents major determinants of adverse prognosis (death, worsening heart failure, heart transplantation) and ongoing LV remodelling (increase in LV volumes) following surgery. Prognosis can also be affected by the presence of LV dyssynchrony, both at rest and during exercise. LV diastolic dysfunction prior to intervention may be another predictor of outcome. Post-intervention exercise test may unmask persistent impairment of diastolic function resulting in clinical worsening independently of recurrent IMR. These data will clarify the link between moderate IMR and outcome. Is poor prognosis due to altered valvular function or related to LV dysfunction?
Evaluating the dynamic behaviour of IMR during exercise prior to surgery can also help predict post-operative responses in terms of MR relief or persistent/recurrent IMR. The absence of functional recovery as assessed by longitudinal function will be associated with IMR persistence and adverse remodelling regardless of whether the mitral valve is repaired or not. Other pre-operative echocardiographic determinants of recurrent IMR will be extensively examined. Greater mitral valve deformation and severe local LV remodelling may play a crucial role and participate in the failure of mitral valve repair. Progressive LV remodelling secondary to the evolution of the ischaemic disease may also affect post-intervention IMR at rest and during exercise.
The dynamic behaviour of IMR can be positively affected or unaltered following surgery. Persistent post-intervention dynamic IMR will be observed in patients in whom IMR is already dynamic pre-operatively. Improvement of IMR may occur in the absence of mitral valve surgery in patients with recruitable contractile reserve in the basal inferior wall and exercise-induced decreases in IMR pre-operatively.
Residual dynamic IMR after intervention may also contribute to reduced post-operative exercise tolerance.
| Conclusion |
|---|
|
|
|---|
The SIMRAM registry is assessing multiple clinical and pathophysiologic aspects of IMR with the goal of providing further insight into the mechanism of IMR and potentially improving current management. This study will also define the place of pre- and post-operative exercise testing in the evaluation of IMR and will provide a list of predictive markers of outcome.
| References |
|---|
|
|
|---|
- Kaul S, Pearlman JD, Touchstone DA, Esquival L. Prevalence and mechanisms of mitral regurgitation in the absence of intrinsic abnormalities of the mitral leaflets. Am Heart J (1989) 118:963–72.[CrossRef][Web of Science][Medline]
- Trichon BH, Felker GM, Shaw LK, Cabell CH, O'Connor CM. Relation of frequency and severity of mitral regurgitation to survival among patients with left ventricular systolic dysfunction and heart failure. Am J Cardiol (2003) 91:538–43.[CrossRef][Web of Science][Medline]
- He S, Fontaine AA, Schwammenthal E, Yoganathan AP, Levine RA. An integrated mechanism for functional mitral regurgitation: leaflet restriction versus coapting force: in vitro studies. Circulation (1997) 96:1826–34.
[Abstract/Free Full Text] - Otsuji Y, Handschumacher MD, Schwammenthal E, Jiang L, Song JK, Guerrero JL, et al. Insights from three-dimensional echocardiography into the mechanism of functional mitral regurgitation. Circulation (1997) 96:1999–2008.
[Abstract/Free Full Text] - Yiu SF, Enriquez-Sarano M, Tribouilloy C, Seward JB, Tajik AJ. Determinants of the degree of functional mitral regurgitation in patients with systolic left ventricular dysfunction. A quantitative clinical study. Circulation (2000) 102:1400–6.
[Abstract/Free Full Text] - Breithardt OA, Sinha AM, Schwammenthal E, Bidaoui N, Markus KU, Franke A, et al. Acute effects of cardiac resynchronization therapy on functional mitral regurgitation in advanced systolic heart failure. J Am Coll Cardiol (2003) 41:765–70.
[Abstract/Free Full Text] - Kanzaki H, Bazaz R, Schwartzman D, Dohi K, Elif Sade L, Gorscan J. A mechanism for immediate reduction in mitral regurgitation after cardiac resynchronization therapy. Insights from mechanical activation strain mapping. J Am Coll Cardiol (2004) 44:1619–25.
[Abstract/Free Full Text] - Watanabe N, Ogasawara Y, Yamaura Y, Wada N, Kawamoto T, Toyota E, et al. Mitral annulus flattens in ischemic mitral regurgitation: geometric differences between inferior and anterior myocardial infarction: a real-time 3-dimensional echocardiographic study. Circulation (2005) 112:I458–62.[Web of Science][Medline]
- Kono T, Sabbah HN, Rosman H, Alam M, Jafri S, Goldstein S. Left ventricular shape is the primary determinant of functional mitral regurgitation in heart failure. J Am Coll Cardiol (1992) 20:1594–8.[Abstract]
- Schwammenthal E, Popescu AC, Popescu BA, Freimark D, Hod H, Eldar M, et al. Mechanism of mitral regurgitation in inferior wall acute myocardial infarction. Am J Cardiol (2002) 90:306–9.[CrossRef][Web of Science][Medline]
- Lamas GA, Mitchell GF, Flaker GC, Smith SC, Gersh BJ, Basta L, et al. Clinical significance of mitral regurgitation after acute myocardial infarction. Survival and ventricular enlargement investigators. Circulation (1997) 96:827–33.
[Abstract/Free Full Text] - Grigioni F, Enriquez-Sarano M, Zehr KJ, Bailey KR, Tajik AJ. Ischemic mitral regurgitation. Long-term outcome and prognostic implications with quantitative Doppler assessment. Circulation (2001) 103:1759–64.
[Abstract/Free Full Text] - Grigioni F, Detaint D, Avierinos JF, Scott C, Tajik J, Enriquez-Sarano M. Contribution of ischemic mitral regurgitation to congestive heart failure after myocardial infarction. J Am Coll Cardiol (2005) 45:260–7.
[Abstract/Free Full Text] - Aklog L, Filsoufi F, Flores KQ, Chen RH, Cohn LH, Nathan NS, et al. Does coronary artery artery bypass grafting alone correct moderate ischemic mitral regurgitation? Circulation (2001) 104:I68–75.[Web of Science][Medline]
- Filsoufi F, Aklog L, Byrne JG, Cohn LH, Adams DH. Current results of combined coronary artery bypass grafting and mitral annuloplasty in patients with moderate ischemic mitral regurgitation. J Heart Valve Dis (2004) 13:747–53.[Web of Science][Medline]
- Trichon BH, Glower DD, Shaw LK, Cabell CH, Anstrom KJ, Felker GM, et al. Survival after coronary revascularization, with and without mitral valve surgery, in patients with ischemic mitral regurgitation. Circulation (2003) 108:II103–10.[Medline]
- Wu AH, Aaronson KD, Bolling SF, Pagani FD, Welch K, Koelling TM. Impact of mitral valve annuloplasty on mortality risk in patients with mitral regurgitation and left ventricular systolic dysfunction. J Am Coll Cardiol (2005) 45:381–7.
[Abstract/Free Full Text] - Bolling SF, Pagani FD, Deeb GM, Bach DS. Intermediate-term outcome of mitral reconstruction in cardiomyopathy. J Thorac Cardiovasc Surg (1998) 115:381–6.
[Abstract/Free Full Text] - Bach DS, Bolling SF. Improvement following correction of secondary mitral regurgitation in end-stage cardiomyopathy with mitral annuloplasty. Am J Cardiol (1996) 78:966–9.[CrossRef][Web of Science][Medline]
- Bax JJ, Braun J, Somer ST, Klautz R, Holman ER, Versteegh MI, et al. Restrictive annuloplasty and coronary revascularization in ischemic mitral regurgitation results in reverse left ventricular remodeling. Circulation (2004) 110:II103–8.[Web of Science][Medline]
- Kang DH, Kim MJ, Kang SJ, Song JM, Song H, Hong MK, et al. Mitral valve repair versus revascularization alone in the treatment of ischemic mitral regurgitation. Circulation (2006) 114:I499–503.[CrossRef][Web of Science][Medline]
- Gillinov AM, Wierup PN, Blackstone EH, Bishay ES, Cosgrove DM, White J, et al. Is repair preferable to replacement for ischemic mitral regurgitation. J Thorac Cardiovasc Surg (2001) 122:1125–41.
[Abstract/Free Full Text] - McGee EC, Gillinov AM, Blackstone EH, Rajeswaran J, Cohen G, Najam F, et al. Recurrent mitral regurgitation after annuloplasty for functional ischemic mitral regurgitation. J Thorac Cardiovasc Surg (2004) 128:916–24.
[Abstract/Free Full Text] - Messas E, Guerrero JL, Handschumacher MD, Conrad C, Chow CM, Sullivan S, et al. Chordal cutting: a new therapeutic approach for ischemic mitral regurgitation. Circulation (2001) 104:1958–63.
[Abstract/Free Full Text] - Tibayan FA, Rodriguez F, Langer F, Zasio MK, Bailey L, Liang D, et al. Annular or subvalvular approach to chronic ischemic mitral regurgitation? J Thorac Cardiovasc Surg (2005) 129:1266–75.
[Abstract/Free Full Text] - Hung J, Papakostas L, Tahta SA, Hardy BG, Bollen BA, Duran CM, et al. Mechanism of recurrent ischemic mitral regurgitation after annuloplasty: continued LV remodeling as a moving target. Circulation (2004) 110:II85–90.[Web of Science][Medline]
- Menicanti L, Di Donato M, Frigiola A, Buckberg G, Santambrogio C, Ranucci M, et al. Ischemic mitral regurgitation: intraventricular papillary muscle imbrication without mitral ring during left ventricular restoration. J Thorac Cardiovasc Surg (2002) 123:1041–50. RESTORE Group.
[Abstract/Free Full Text] - Acker MA, Bolling S, Shemin R, Kirklin J, Oh JK, Mann DL, et al. Acorn Trial Principal Investigators and Study Coordinators. Mitral valve surgery in heart failure: insights from the Acorn Clinical Trial. J Thorac Cardiovasc Surg (2006) 132:568–77.
[Abstract/Free Full Text] - Piérard L, Lancellotti P. Stress testing in valvular heart disease. In: Heart (2007) 93:766–72.
[Free Full Text] - Lancellotti P, Piérard LA. Echocardiographie dynamique dans l'insuffisance mitrale. Arch Mal Cœur (2002) 95:793–8.
- Levine RA, Hung J. Ischemic mitral regurgitation, the dynamic lesion: clues to the cure. J Am Coll Cardiol (2003) 42:1929–32.
[Free Full Text] - Levine RA, Schwammenthal E. Ischemic mitral regurgitation on the threshold of a solution: from paradoxes to unifying concepts. Circulation (2005) 112:745–58.
[Free Full Text] - Levine RA. Dynamic mitral regurgitation—more than meets the eye. N Engl J Med (2004) 351:1681–84.
[Free Full Text] - Piérard LA, Lancellotti P. Dyspnea and stress testing. N Engl J Med (2006) 354:871–3.
[Free Full Text] - Lebrun F, Lancellotti P, Piérard LA. Quantitation of functional mitral regurgitation during bicycle exercise in patients with heart failure. J Am Coll Cardiol (2001) 38:1685–1692.
[Abstract/Free Full Text] - Lancellotti P, Lebrun F, Piérard LA. Determinants of exercise-induced changes in mitral regurgitation in patients with coronary artery disease and left ventricular dysfunction. J Am Coll Cardiol (2003) 42:1921–8.
[Abstract/Free Full Text] - Giga V, Ostojic M, Vujisic-Tesic B, Djordjevic-Dikic A, Stepanovic J, et al. Exercise-induced changes in mitral regurgitation in patients with prior myocardial infarction and left ventricular dysfunction: relation to mitral deformation and left ventricular function and shape. Eur Heart J (2005) 26:1860–5.
[Abstract/Free Full Text] - Lancellotti P, Stainier PY, Lebois F, Piérard LA. Effect of dynamic left ventricular dyssynchrony on dynamic mitral regurgitation in patients with heart failure due to coronary artery disease. Am J Cardiol (2005) 96:1304–7.[CrossRef][Web of Science][Medline]
- Ennezat PV, Marechaux S, Le Tourneau T, Lamblin N, Bauters C, Van Belle E, et al. Myocardial asynchronism is a determinant of changes in functional mitral regurgitation severity during dynamic exercise in patients with chronic heart failure due to severe left ventricular systolic dysfunction. Eur Heart J (2006) 27:679–83.
[Abstract/Free Full Text] - Lafitte S, Bordachar P, Lafitte M, Garrigue S, Reuter S, Reant P, et al. Dynamic ventricular dyssynchrony: an exercise-echocardiography study. J Am Coll Cardiol (2006) 47:2253–9.
[Abstract/Free Full Text] - Lancellotti P, Mélon P, Sakalihasan N, Waleffe A, Dubois C, Bertholet M, et al. Effects of cardiac resynchronization therapy on functional mitral regurgitation in heart failure. Am J Cardiol (2004) 94:1462–65.[CrossRef][Web of Science][Medline]
- Lancellotti P, Piérard LA. Chronic ischaemic mitral regurgitation: exercise testing reveals its dynamic component. Eur Heart J (2005) 26:1816–7.
[Free Full Text] - Piérard LA, Lancellotti P. The role of ischemic mitral regurgitation in the pathogenesis of acute pulmonary edema. N Engl J Med (2004) 351:1627–34.
[Abstract/Free Full Text] - Lancellotti P, Kulbertus HE, Piérard LA. Predictors of rapid QRS widening in patients with coronary arery disease and left ventricular dysfunction. Am J Cardiol (2004) 93:1410–12.[CrossRef][Web of Science][Medline]
- Lancellotti P, Troisfontaines P, Toussaint A-C, Piérard LA. Prognostic importance of exercise-induced changes in mitral regurgitation in patients with chronic ischemic left ventricular dysfunction. Circulation (2003) 108:1713–7.
[Abstract/Free Full Text] - Lancellotti P, Gérard P, Piérard L. Long term outcome of patients with heart failure and dynamic mitral regurgitation. Eur Heart J (2005) 26:1528–32.
[Abstract/Free Full Text] - Enriquez-Sarano M, Seward J, Bailey K, Tajik A. Effective regurgitant orifice area: a noninvasive Doppler development of an old hemodynamic concept. J Am Coll Cardiol (1994) 23:443–51.[Abstract]
- Grossi EA, Crooke GA, DiGiorgi PL, Schwartz CF, Jorde U, Applebaum RM, et al. Impact of moderate functional mitral insufficiency in patients undergoing surgical revascularization. Circulation (2006) 114:I573–6.[CrossRef][Web of Science][Medline]
- Di Mauro M, Di Giammarco G, Vitolla G, Contini M, Iaco AL, Bivona A, et al. Impact of no-to-moderate mitral regurgitation on late results after isolated coronary artery bypass grafting in patients with ischemic cardiomyopathy. Ann Thorac Surg (2006) 81:2128–34.
[Abstract/Free Full Text]
This article has been cited by other articles:
![]() |
E. Picano, P. Pibarot, P. Lancellotti, J. L. Monin, and R. O. Bonow The emerging role of exercise testing and stress echocardiography in valvular heart disease. J. Am. Coll. Cardiol., December 8, 2009; 54(24): 2251 - 2260. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Lancellotti, T. Marwick, and L. A Pierard How to manage ischaemic mitral regurgitation Heart, November 1, 2008; 94(11): 1497 - 1502. [Full Text] [PDF] |
||||
![]() |
R. Sicari, P. Nihoyannopoulos, A. Evangelista, J. Kasprzak, P. Lancellotti, D. Poldermans, J.-U. Voigt, J. L. Zamorano, and on behalf of the European Association of Echocardi Stress echocardiography expert consensus statement: European Association of Echocardiography (EAE) (a registered branch of the ESC) Eur J Echocardiogr, July 1, 2008; 9(4): 415 - 437. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Agricola, M. Oppizzi, M. Pisani, A. Meris, F. Maisano, and A. Margonato Ischemic mitral regurgitation: mechanisms and echocardiographic classification Eur J Echocardiogr, March 1, 2008; 9(2): 207 - 221. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||


